IDrugs. 2010 Aug;13(8):539-42.

The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders.

Source

Southern General Hospital, Department of Neurology, Institute of Neurological Sciences, Glasgow, UK. d.grosset@clinmed.gla.ac.uk

Abstract

The 14th International Congress of Parkinson's Disease and Movement Disorders, held in Buenos Aires, included topics covering new therapeutic developments in the field of Parkinson's disease and other movement disorders. This conference report highlights selected presentations on drug treatments for movement disorders, including safinamide (Merck Serono SA), PYM-50028 (Phytopharm plc), droxidopa, pardoprunox (Abbott Laboratories); treatment considerations for dystonia; exploiting existing drugs for new indications; and using genetics to assess drug therapy responses.

PMID:: 20721824; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Congresses

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Related citations

Parkinson's disease and related disorders--XVIII WFN World Congress. [IDrugs. 2010]
Parkinson's disease and related disorders--XVIII WFN World Congress.
Grosset D. IDrugs. 2010 Feb; 13(2):82-4.
Parkinson's disease: an enigma: highlights from the 8th International Congress of Parkinson's Disease and Movement Disorders, June 13-17, 2004, Rome, Italy. [Rev Neurol Dis. 2005]
Parkinson's disease: an enigma: highlights from the 8th International Congress of Parkinson's Disease and Movement Disorders, June 13-17, 2004, Rome, Italy.
Weiner WJ. Rev Neurol Dis. 2005 Winter; 2(1):20-2.
[Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)]. [Therapeutique. 1972]
[Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
Sigwald J. Therapeutique. 1972 Nov; 48(9):561-8.
Review Therapeutic strategies to prevent motor complications in Parkinson's disease. [J Neurol. 2008]
Review Therapeutic strategies to prevent motor complications in Parkinson's disease.
Kieburtz K. J Neurol. 2008 Aug; 255 Suppl 4:42-5.
Review Parkinson's disease: emerging pharmacotherapy. [Expert Opin Emerg Drugs. 2008]
Review Parkinson's disease: emerging pharmacotherapy.
Strecker K, Schwarz J. Expert Opin Emerg Drugs. 2008 Dec; 13(4):573-91.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

The Movement Disorder Society--14th International Congress of Parkinson's Diseas...
The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders.
IDrugs. 2010 Aug ;13(8):539-42.

PubMed
Simultaneous mutation detection in 90 retinal disease genes in multiple patients...
Simultaneous mutation detection in 90 retinal disease genes in multiple patients using a custom-designed 300-kb retinal resequencing chip.
Ophthalmology. 2011 Jan ;118(1):160-167.e1-3.

PubMed
Overexpression of taurine transporter in Chinese hamster ovary cells can enhance...
Overexpression of taurine transporter in Chinese hamster ovary cells can enhance cell viability and product yield, while promoting glutamine consumption.
Biotechnol Bioeng. 2010 Dec 15 ;107(6):998-1003.

PubMed
Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three diff...
Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.
Eur Radiol. 2011 Feb ;21(2):337-44. Epub 2010 Sep 1 .

PubMed
Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on car...
Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on cardiac function and metabolism.
Cardiovasc Diabetol. 2010 Aug 24 ;9:43.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: